SVP, Chief Financial Officer
Mr. Kalb joined Amarin in June 2016 as senior vice president, chief financial officer. He has over 20 years of international financial operations and accounting advisory experience. Prior to Amarin, Mr. Kalb served as chief financial officer and chief accounting officer of Taro Pharmaceutical Industries, Ltd., a publicly-traded, multinational, science-based pharmaceutical company. Prior to joining Taro, Mr. Kalb was a director in the Accounting and Financial Consulting Group of Huron Consulting Group Inc. Mr. Kalb's experience also includes over ten years at Ernst & Young, LLP within its Transaction Advisory Services Group and Audit and Assurance Services Group. He is a certified public accountant.
commercialization and development of therapeutics to improve cardiovascular health. Amarin's product development program leverages its extensive experience in lipid science and the potential therapeutic benefits of polyunsaturated fatty acids